Novo Nordisk shares tumble 11% after company forecasts sales declines this year

Novo Nordisk's U.S. shares plummeted late Tuesday after the company said it sees sales and profit growth declining this year, expecting a sales hit.The company published the forecast as it reported full-year 2025 sales, ahead of the quarterly report expected Wednesday morning. Novo's American depositary shares fell 11% as of 12:05 pm ET. The results were published after the closing bell in Copenhagen, where the company has its primary listing.Its forecast comes as the Danish drugmaker is fighting to regain ...